Risk stratification in patients with chronic heart failure based on metabolic-immunological, functional and haemodynamic parameters

International Journal of Cardiology

Volumn 156, Issue 1, 2012, Pages 62-68

  Herrmann, Ralph ^a   Sandek, Anja ^a,d   Von Haehling, Stephan ^a   Doehner, Wolfram ^a   Schmidt, Hendrik B ^b   Anker, Stefan D ^a,c   Rauchhaus, Mathias ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Klinikum Magdeburg   (Germany)

^c IRCCS SAN RAFFAELE PISANA   (Italy)

^d IRCCS San Raffaele ^*  (Germany)

Author keywords

Cholesterol; Chronic heart failure; Inflammation; Mortality; Prognosis; Uric acid

Indexed keywords

CHOLESTEROL; TUMOR NECROSIS FACTOR RECEPTOR 1; URIC ACID;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FUNCTIONAL ASSESSMENT; HEART FAILURE; HEART FUNCTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE OXYGEN CONSUMPTION; HEMODYNAMIC PARAMETERS; HUMAN; IMMUNOLOGICAL PARAMETERS; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; MORTALITY; NEW YORK HEART ASSOCIATION FUNCTIONAL CLASS; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; URIC ACID BLOOD LEVEL;

EID: 84858080793     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.10.028     Document Type: Article

References (42)

1. J.J. McMurray, and S. Stewart Epidemiology, aetiology, and prognosis of heart failure Heart 83 2000 596 602 (Pubitemid 30316742)
2. A.D. Galbreath, R.A. Krasuski, and B. Smith Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure Circulation 110 2004 3518 3526 (Pubitemid 39612565)
3. S. von Haehling, J.C. Schefold, M. Lainscak, W. Doehner, and S.D. Anker Inflammatory biomarkers in heart failure revisited: much more than innocent bystanders Heart Fail Clin 5 2009 549 560
4. F.M. Sacks, M.A. Pfeffer, and L.A. Moye The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators N Engl J Med 335 1996 1001 1009 (Pubitemid 26338729)
5. C. Kistorp, J. Faber, and S. Galatius Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure Circulation 112 2005 1756 1762 (Pubitemid 41372115)
6. J.N. Cohn Physiologic variables as markers for symptoms, risk and interventions in heart failure Circulation VII 87 1993 110 suppl
7. S. von Haehling, M. Lainscak, J. Springer, and S.D. Anker Cardiac cachexia: a systematic overview Pharmacol Ther 121 2009 227 252
8. A. Sandek, M. Rauchhaus, S.D. Anker, and S. von Haehling The emerging role of the gut in chronic heart failure Curr Opin Clin Nutr Metab Care 11 2008 632 639
9. A. Sandek, S.D. Anker, and S. von Haehling The gut and intestinal bacteria in chronic heart failure Curr Drug Metab 10 2009 22 28
10. M. Dhir, and S.F. Nagueh Echocardiography and prognosis of heart failure Am J Cardiol 17 2002 253 257
11. L. Grigorian Shamagian, J.R. Gonzalez-Juanatey, A.V. Roman, J.M. Acuña, and A.V. Lamela The death rate among hospitalized heart failure patients with normal and depressed left ventricular ejection fraction in the year following discharge: evolution over a 10-year period Eur Heart J 26 2005 2251 2258 (Pubitemid 41541388)
12. L.C. Davies, R. Wensel, and P. Georgiadou Enhanced prognostic value from cardiopulmonary exercise testing in chronic heart failure by non-linear analysis: oxygen uptake efficiency slope Eur Heart J 27 2006 684 690
13. P. Agostoni, M. Bussotti, and G. Cattadori Gas diffusion and alveolar-capillary unit in chronic heart failure Eur Heart J 27 2006 2538 2543 (Pubitemid 44627297)
14. S.D. Anker, W. Doehner, and M. Rauchhaus Uric acid and survival in chronic heart failure: validation and application in metabolic-immunological, functional and hemodynamic staging Circulation 107 2003 1991 1997 (Pubitemid 36506072)
15. A. Strasak, E. Ruttmann, and L. Brant Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83 683 Austrian men Clin Chem 54 2008 273 284 (Pubitemid 351302628)
16. M. Rauchhaus, W. Doehner, and D.P. Francis Plasma cytokine parameters and mortality in patients with chronic heart failure Circulation 102 2000 3060 3067
17. M. Rauchhaus, A.l. Clark, and W. Doehner The relationship between cholesterol and survival in patients with chronic heart failure J Am Coll Cardiol 40 2003 1933 1940 (Pubitemid 37485568)
18. T.B. Horwich, M.A. Hamilton, W.R. Maclellan, and G.C. Fonarow Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure J Card Fail 8 2002 216 224
19. S.D. Anker, T.P. Chua, and P. Ponikowski Hormonal changes and catabolic/anabolic inbalance in chronic heart failure and their importance for cardiac cachexia Circulation 96 1997 526 534 (Pubitemid 27329429)
20. S.D. Anker, and A.J. Coats Metabolic-immunological, functional, and haemodynamic staging for CHF? Lancet 348 1996 1530 1531 (Pubitemid 26411646)
21. C. Bergamini, M. Cicoira, A. Rossi, and C. Vassanelli Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure Eur J Heart Fail 11 2009 444 452
22. E. Jarasch, C. Grund, G. Bruder, H.W. Heid, T.W. Keenan, and W.W. Franke Localization of xanthine oxidase in mammary gland epithelium and capillary endothelium Cell 25 1981 67 82 (Pubitemid 11087436)
23. F. Roch-Ramel, B. Guisan, and J. Diezi Effects of uricosuric and antiuricosuric agents on urate transport in human brush-border membrane vesicles J Pharmacol Exp Ther 280 1997 839 845 (Pubitemid 27171347)
24. A. Høieggen, M.H. Alderman, and S.E. Kjeldsen The impact of serum uric acid on cardiovascular outcomes in the life study Kidney Int 65 2004 1041 1049 (Pubitemid 38251080)
25. M. Rauchhaus, W. Doehner, and D.P. Francis Plasma cytokine parameters and mortality in patients with chronic heart failure Circulation 102 2000 3060 3067
26. J.G. Cleland, A.P. Coletta, and A.L. Clark Clinical trials update from the joint European Society and World Congress of Cardiology meeting: PEP-CHF, ACCLAIM and the HHH study Eur J Heart Fail 8 2006 658 661 (Pubitemid 44572964)
27. M. Satoh, Y. Minami, Y. Takahashi, and M. Nakamura Immune modulation: role of the inflammatory cytokine cascade in the failing human heart Curr Heart Fail Rep 5 2008 69 74
28. B.M. Richartz, B. Radovancevic, O.H. Frazier, W.K. Vaughn, and H. Taegtmeyer Low serum cholesterol levels predict high perioperative mortality in patients supported by a left-ventricular assist system Cardiol 89 1998 184 188 (Pubitemid 28116089)
29. The Scandinavian Simvastatin Survival Study Group Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
30. E.T. Poehlman, J. Scheffers, S.S. Gottlieb, M.L. Fischer, and P. Vaitekevicius Increased resting metabolic-immunological rate in patients with congestive heart failure Ann Intern Med 121 1994 860 862
31. P. Velavan, P. Huan Loh, A. Clark, and J.G. Cleland The cholesterol paradox in heart failure Congest Heart Fail 13 2007 336 341
32. J. Kjekshus, E. Apetrei, and V. Barrios Rosuvastatin in older patients with systolic heart failure N Engl J Med 357 2007 2248 2261 (Pubitemid 350190755)
33. D. Mancini, T. LeJemtel, and K. Aaronson Peak VO(2): a simple yet enduring standard Circulation 101 2000 1152 1157
34. C.C. Lang, P. Karlin, J. Haythe, L. Tsao, and D.M. Mancini Ease of noninvasive measurement of cardiac output coupled with peak VO2 determination at rest and during exercise in patients with heart failure Am J Cardiol 99 2007 404 405 (Pubitemid 46149559)
35. D.M. Mancini, H. Eisen, W. Kussmaul, R. Mull, L.H. Edmunds, and J.R. Wilson Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure Circulation 83 1991 778 786
36. A. Sachdeva, T.B. Horwich, and G.C. Fonarow Comparison of usefulness of each of five predictors of mortality and urgent transplantation in patients with advanced heart failure Am J Cardiol 106 2010 830 835
37. J.R. Corbett, G.J. Dehmer, and S.E. Lewis The prognostic value of submaximal exercise testing with radionuclide ventriculography before hospital discharge in patients with recent myocardial infarction Circulation 64 1981 535 544 (Pubitemid 11061622)
38. P.R. Marantz, J.N. Tobin, and S. Wassertheil-Smoller The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria Circulation 77 1988 607 612 (Pubitemid 18073352)
39. T. Takamura, K. Onishi, and T. Sugimoto Patients with a hypertensive response to exercise have impaired left ventricular diastolic function Hypertens Res 31 2008 257 263 (Pubitemid 351461105)
40. A.T. Burns, A. La Gerche, A.I. MacIsaac, and D.L. Prior Augmentation of left ventricular torsion with exercise is attenuated with age J Am Soc Echocardiogr 21 2008 315 320
41. R. Berger, M. Huelsman, and K. Strecker B-type natriuretic peptide predicts sudden death in patients with chronic heart failure Circulation 105 2002 2392 2397 (Pubitemid 34556391)
42. A. Maisel, J.E. Hollander, and D. Guss Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath J Am Coll Cardiol 44 2004 1328 1333 (Pubitemid 39208893)